ELEV vs. IDYA

Last updated Apr 1, 2026

Compare and contrast key facts about Elevation Oncology Inc (ELEV) and IDEAYA Biosciences, Inc. (IDYA).

Performance

ELEV vs. IDYA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Elevation Oncology Inc (ELEV) and IDEAYA Biosciences, Inc. (IDYA). The values are adjusted to include any dividend payments, if applicable.

ELEV vs. IDYA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ELEV Elevation Oncology Inc	0.00%	-35.12%	4.77%	-43.47%	-84.22%	-47.38%
IDYA IDEAYA Biosciences, Inc.	-3.62%	34.51%	-27.77%	95.82%	-23.14%	9.90%

Fundamentals

Total Revenue (TTM) ELEV : $38.00K IDYA : $218.71M
Gross Profit (TTM) ELEV : $5.00K IDYA : $214.12M
EBITDA (TTM) ELEV : -$47.86M IDYA : -$120.40M

Returns By Period

ELEV

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

IDYA

• 1D: 5.95%
• 1M: 3.48%
• YTD: -3.62%
• 6M: 22.45%
• 1Y: 103.42%
• 3Y*: 34.38%
• 5Y*: 6.93%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ELEV vs. IDYA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDYA

IDYA Risk / Return Rank: 89
IDYA Sharpe Ratio Rank: 90
IDYA Sortino Ratio Rank: 86
IDYA Omega Ratio Rank: 84
IDYA Calmar Ratio Rank: 93
IDYA Martin Ratio Rank: 92

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELEV vs. IDYA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Elevation Oncology Inc (ELEV) and IDEAYA Biosciences, Inc. (IDYA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	ELEV	IDYA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.98	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.12	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.23	—

Correlation

The correlation between ELEV and IDYA is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ELEV vs. IDYA - Dividend Comparison

Neither ELEV nor IDYA has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	ELEV	IDYA	Difference
Max Drawdown Largest peak-to-trough decline	—	-74.64%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-20.05%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-69.42%	—
Current Drawdown Current decline from peak	—	-29.30%	—
Average Drawdown Average peak-to-trough decline	—	-30.82%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	7.92%	—

Volatility

Volatility by Period

	ELEV	IDYA	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	15.78%	—
Volatility (6M) Calculated over the trailing 6-month period	—	31.74%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	52.65%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	59.78%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	74.51%	—

Financials